Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 726.49 billion as of February 10, 2026. Its market cap has decreased by -0.06% in one year.

Market Cap

726.49B

Enterprise Value

727.33B

Revenue

58.88B

Ranking

n/a

PE Ratio

909.17

Stock Price

8,380.00

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 1.32B to 726.49B, an increase of 54,820.97%. That is a compound annual growth rate of 33.71%.

Market Cap History

Date	Market Cap	% Change
Feb 9, 2026	726.49B	-23.19%
Dec 31, 2025	945.80B	49.55%
Dec 31, 2024	632.43B	55.74%
Dec 29, 2023	406.09B	-28.80%
Dec 30, 2022	570.31B	37.16%
Dec 31, 2021	415.79B	38.38%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1.01T
Grupo Financiero Banorte	579.64B
Industrias Peñoles	436.97B
Arca Continental	348.22B
FIBRA Prologis	138.53B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	124.25B
Fibra UNO	109.90B
Grupo Elektra	91.63B

Market Cap Rankings